Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (<scp>MACVIA</scp>‐<scp>ARIA</scp>) ‐ <scp>EIP</scp> on <scp>AHA</scp> Twinning Reference Site (<scp>GARD</scp> research demonstration project)Jean Bousquet, Francesca Corti, Ioana Agache et al.|Allergy|2017Cited by 63
Body mass index (BMI) and outcome of metastatic melanoma patients receiving targeted therapy and immunotherapy: a multicenter international retrospective studyPiotr Rutkowski, Mario Mandalà, Lorenza Di Guardo et al.|Journal for ImmunoTherapy of Cancer|2020Cited by 60
Combination of Immunotherapy and Brain Radiotherapy in Metastatic Melanoma: A Retrospective AnalysisGiulia Galli, Michele Del Vecchio, Stefano Cavalieri et al.|Oncology Research and Treatment|2019Cited by 25
Liquid Biopsy and Radiological Response Predict Outcomes Following Discontinuation of Targeted Therapy in Patients with <i>BRAF</i> Mutated MelanomaLorenza Di Guardo, Michele Del Vecchio, Giovanni Randon et al.|The Oncologist|2021Cited by 10
Risk of disease progression (PD) following discontinuation of BRAF±MEK targeted therapies for reasons other than PD in patients (pts) with metastatic or unresectable melanoma.Francesca Corti, Lorenza Di Guardo, Giovanni Randon et al.|Journal of Clinical Oncology|2020Cited by 4